已收盤 09-05 16:00:00 美东时间
+0.140
+1.01%
Oaktree Specialty Lending's (NASDAQ:OCSL) fiscal third-quarter earnings, released Tuesday, came in worse than expected as "certain non-cash items impacted net investment income this quarter," said CEO...
08-05 21:40
Oaktree Specialty Lending (NASDAQ:OCSL) declares $0.40/share quarterly dividend, in line with previous. Forward yield 11.84% Payable Sept. 30; for shareholders of record Sept. 15; ex-div Sept. 15. See...
08-05 21:26
Companies Reporting Before The Bell • Silicon Laboratories (NASDAQ:SLAB) is exp...
08-05 16:32
Oaktree Specialty Lending (NASDAQ:OCSL) is scheduled to announce FQ3 earnings results on Tuesday, August 5th, before market open. The consensus EPS Estimate is $0.45 and the consensus Revenue Estimate...
08-05 00:21
Data analytics and technology provider Verisk Analytics (NASDAQ:VRSK) announced on Thursday the acquisition of SuranceBay for a cash consideration of $162.5M. SuranceBay provides producer licensing, o...
07-17 21:44
Oaktree Specialty Lending Corporation (NASDAQ:OCSL) announced it will release its third fiscal quarter financial results ended June 30, 2025 before the opening of Nasdaq on August 5, 2025. Management will host a conference call at 11:00 a.m. Eastern Time / 8:00 a.m. Pacific Time to discuss the results. Call details and a live webcast can be accessed via the Investor Relations section of the company's website. A replay will be available later. Oak...
07-02 20:00
As private credit continues to gain traction in institutional portfolios and th...
06-13 02:53
Deutsche Bank (NYSE:DB), Germany's largest lender, is exploring whether to issue its own stablecoin, as well as develop its own tokenized deposit solution for payments, according to a media report pub...
06-07 00:25
CRISPR Therapeutics (NASDAQ:CRSP) and Sirius Therapeutics have formed a partnership to jointly develop and commercialize small interfering RNA (siRNA) therapies. The collaboration will initially focus...
05-20 21:50
A big breakthrough is being hailed in the world of gene editing, with the first custom-designed treatment using CRISPR technology (NASDAQ:CRSP). The therapy was developed for an infant named KJ Muloon...
05-16 18:54